1. Murray CJ, Lopez AD (1997) Mortality by cause for eight regions of the world: global Burden of Disease Study. Lancet ; 349: 1269-1276. https://doi.org/10.1016/S0140-6736(96)07493-4
2. Ridker PM, MacFadyen JG, Thuren T, Libby P (2020) Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis. Eur Heart J 41:2153-2163. https://doi.org/10.1093/eurheartj/ehz542
3. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ, CANTOS Trial Group (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377:1119-11131. https://doi.org/10.1056/NEJMoa1707914
4. Ridker PM, MacFadyen JG, Glynn RJ, Bradwin G, Hasan AA, Rifai N (2020) Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the cardiovascular Inflammation Reduction Trial. Eur Heart J ; 41: 2952-2961. https://doi.org/10.1093/eurheartj/ehaa160
5. Ridker PM, MacFadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ, CANTOS Trial Group (2018) Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet 391:319-328. https://doi.org/10.1016/S0140-6736(17)32814-3
6. Ridker PM, Libby P, MacFadyen JG, Thuren T, Ballantyne C, Fonseca F, Koenig W, Shimokawa H, Everett BM, Glynn RJ (2018) Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Eur Heart J 39:3499-3507. https://doi.org/10.1093/eurheartj/ehy310
7. Nakanishi R, Berman DS, Budoff MJ, Gransar H, Achenbach S, Al-Mallah M, Andreini D, Cademartiri F, Callister TQ, Chang HJ, Cheng VY, Chinnaiyan K, Chow BJ, Cury R, Delago A, Hadamitzky M, Hausleiter J, Feuchtner G, Kim YJ, Kaufmann PA, Leipsic J, Lin FY, Maffei E, Pontone G, Raff G, Shaw LJ, Villines TC, Dunning A, Min JK (2015) Current but not past smoking increases the risk of cardiac events: insights from coronary computed tomographic angiography. Eur Heart J 36:1031-1040. https://doi.org/10.1093/eurheartj/ehv013
8. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, Flores FR, Callister TQ, Raggi P, Berman DS (2007) Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 49:1860-1870. https://doi.org/10.1016/j.jacc.2006.10.079
9. Budoff MJ, Nasir K, Katz R, Takasu J, Carr JJ, Wong ND, Allison M, Lima JA, Detrano R, Blumenthal RS, Kronmal R (2011) Thoracic aortic calcification and coronary heart disease events: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 215:196-202. https://doi.org/10.1016/j.atherosclerosis.2010.11.017
10. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827-832. https://doi.org/10.1016/0735-1097(90)90282-t
11. Dunphy MP, Freiman A, Larson SM, Strauss HW (2005) Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med 46:1278-1284.
12. Raggi P, Callister TQ, Cooil B, He ZX, Lippolis NJ, Russo DJ, Zelinger A, Mahmarian JJ (2000) Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 101:850-855. https://doi.org/10.1161/01.cir.101.8.850
13. Tota-Maharaj R, Blaha MJ, McEvoy JW, Blumenthal RS, Muse ED, Budoff MJ, Shaw LJ, Berman DS, Rana JS, Rumberger J, Callister T, Rivera J, Agatston A, Nasir K (2012) Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old. Eur Heart J 33:2955-2962. https://doi.org/10.1093/eurheartj/ehs230
14. Kaim AH, Weber B, Kurrer MO, Gottschalk J, Von Schulthess GK, Buck A (2002) Autoradiographic quantification of 18F-FDG uptake in experimental soft-tissue abscesses in rats. Radiology 223:446-451. https://doi.org/10.1148/radiol.2232010914
15. Osman S, Danpure HJ (1992) The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B 19:183-190. https://doi.org/10.1016/0883-2897(92)90006-k
16. Yun M, Yeh D, Araujo LI, Jang S, Newberg A, Alavi A (2001) F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 26:314-319. https://doi.org/10.1097/00003072-200104000-00007
17. Ben-Haim S, Kupzov E, Tamir A, Israel O (2004) Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med 45:1816-1821.
18. Rose S, Sheth NH, Baker JF, Ogdie A, Raper A, Saboury B, Werner TJ, Thomas P, Vanvoorhees A, Alavi A, Torigian DA, Gelfand JM, Mehta NN (2013) A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study. Am J Cardiovasc Dis 3:273-278.
19. Yoon HE, Kim Y, Kim SD, et al (2018) A pilot trial to examine the changes in carotid arterial inflammation in renal transplant recipients as assessed by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography computed tomography (PET/CT). Ann Transplant ; 23: 412-421. https://doi.org/10.12659/AOT.909212
20. Joshi FR, Rajani NK, Abt M, Woodward M, Bucerius J, Mani V, Tawakol A, Kallend D, Fayad ZA, Rudd JH (2013) Does vascular calcification accelerate inflammation?: a substudy of the dal-PLAQUE Trial. J Am Coll Cardiol 67:69-78. https://doi.org/10.1016/j.jacc.2015.10.050
21. Nakahara T, Narula J, Fox JJ, Jinzaki M, Strauss HW (2021) Temporal relationship between 18F-sodium fluoride uptake in the abdominal aorta and evolution of CT-verified vascular calcification. J Nucl Cardiol 28:1936-1945. https://doi.org/10.1007/s12350-019-01934-2
22. Okubo R, Nakanishi R, Dailing C, Yabe T, Noike R, Matsumoto S, Aikawa H, Okamura Y, Hashimoto H, Amano H, Toda M, Maehara A, Budoff MJ, Ikeda T (2020) The relationship between coronary artery calcium density and optical coherence tomography-derived plaque characteristics. Atherosclerosis 311:30-36. https://doi.org/10.1016/j.atherosclerosis.2020.08.010
23. Doris MK, Meah MN, Moss AJ, Andrews JPM, Bing R, Gillen R, Weir N, Syed M, Daghem M, Shah A, Williams MC, van Beek EJR, Forsyth L, Dey D, Slomka PJ, Dweck MR, Newby DE, Adamson PD (2020) Coronary 18F-fluoride uptake and progression of coronary artery calcification. Circ Cardiovasc Imaging 13:e011438. https://doi.org/10.1161/CIRCIMAGING.120.011438
24. Niccoli Asabella A, Ciccone MM, Cortese F, Scicchitano P, Gesualdo M, Zito A, Di Palo A, Angiletta D, Regina G, Marzullo A, Rubini G (2014) Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study. Ann Nucl Med 28:571-579. https://doi.org/10.1007/s12149-014-0850-9
25. Iwatsuka R, Matsue Y, Yonetsu T, O’uchi T, Matsumura A, Hashimoto Y, Hirao K (2018) Arterial inflammation measured by 18F-FDG-PET-CT to predict coronary events in older subjects. Atherosclerosis 268:49-54. https://doi.org/10.1016/j.atherosclerosis.2017.11.016
26. Johnsrud K, Skagen K, Seierstad T, Skjelland M, Russell D, Revheim ME (2019) 18F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques. J Nucl Cardiol 26:883-893. https://doi.org/10.1007/s12350-017-1121-7
27. Choi YS, Youn HJ, Chung WB, Hwang HJ, Lee DH, Park CS, Lee JB, Kim PJ, Chung WS, Lee MY, Seung KB, Chung YA (2011) Uptake of F-18 FDG and ultrasound analysis of carotid plaque. J Nucl Cardiol 18:267-272. https://doi.org/10.1007/s12350-011-9338-3
28. Hetterich H, Rominger A, Walter L, Habs M, Volpers S, Hacker M, Reiser MF, Bartenstein P, Saam T (2016) Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT. Int J Cardiovasc Imaging 32:49-59. https://doi.org/10.1007/s10554-015-0660-8